Business Description
Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.25 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | -8.67 | |||||
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.03 | |||||
| 9-Day RSI | 58.72 | |||||
| 14-Day RSI | 56.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.64 | |||||
| Quick Ratio | 4.57 | |||||
| Cash Ratio | 4.49 | |||||
| Days Inventory | 147.83 | |||||
| Days Sales Outstanding | 33.2 | |||||
| Days Payable | 13.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.68 | |||||
| Operating Margin % | -29.17 | |||||
| Net Margin % | -34.57 | |||||
| ROE % | -6.05 | |||||
| ROA % | -4.18 | |||||
| ROIC % | -17.96 | |||||
| ROC (Joel Greenblatt) % | -109.06 | |||||
| ROCE % | -4.89 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.02 | |||||
| PB Ratio | 4.72 | |||||
| Price-to-Tangible-Book | 4.73 | |||||
| EV-to-EBIT | -65.02 | |||||
| EV-to-EBITDA | -80.67 | |||||
| EV-to-Revenue | 21.75 | |||||
| EV-to-FCF | -36.65 | |||||
| Price-to-Net-Current-Asset-Value | 5.41 | |||||
| Price-to-Net-Cash | 5.69 | |||||
| Earnings Yield (Greenblatt) % | -1.54 |
How Cyfuse Biomedical KK (TSE:4892) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 332.504 | ||
| EPS (TTM) (円) | -16.088 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 56.82 | ||
| 14-Day ATR (円) | 121.611416 | ||
| 20-Day SMA (円) | 1106.05 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (円) | 922 - 2468 | ||
| Shares Outstanding (Mil) | 7.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyfuse Biomedical KK Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyfuse Biomedical KK Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cyfuse Biomedical KK Frequently Asked Questions
What is Cyfuse Biomedical KK(TSE:4892)'s stock price today?
The current price of TSE:4892 is 円1257.00. The 52 week high of TSE:4892 is 円2468.00 and 52 week low is 円922.00.
When is next earnings date of Cyfuse Biomedical KK(TSE:4892)?
The next earnings date of Cyfuse Biomedical KK(TSE:4892) is .
Does Cyfuse Biomedical KK(TSE:4892) pay dividends? If so, how much?
Cyfuse Biomedical KK(TSE:4892) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
